↓ Skip to main content

The natural history of EGFR and EGFRvIII in glioblastoma patients

Overview of attention for article published in Journal of Translational Medicine, October 2005
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
patent
1 patent

Citations

dimensions_citation
177 Dimensions

Readers on

mendeley
150 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The natural history of EGFR and EGFRvIII in glioblastoma patients
Published in
Journal of Translational Medicine, October 2005
DOI 10.1186/1479-5876-3-38
Pubmed ID
Authors

Amy B Heimberger, Dima Suki, David Yang, Weiming Shi, Kenneth Aldape

Abstract

The epidermal growth factor receptor (EGFR) is over expressed in approximately 50-60% of glioblastoma (GBM) tumors, and the most common EGFR mutant, EGFRvIII, is expressed in 24-67% of cases. This study was designed to address whether over expressed EGFR or EGFRvIII is an actual independent prognostic indicator of overall survival in a uniform body of patients in whom gross total surgical resection (GTR; > or = 95% resection) was not attempted or achieved.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 150 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 <1%
Italy 1 <1%
Brazil 1 <1%
India 1 <1%
Nigeria 1 <1%
United States 1 <1%
Unknown 144 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 29 19%
Student > Ph. D. Student 26 17%
Student > Bachelor 18 12%
Student > Master 17 11%
Student > Postgraduate 11 7%
Other 17 11%
Unknown 32 21%
Readers by discipline Count As %
Medicine and Dentistry 40 27%
Agricultural and Biological Sciences 30 20%
Biochemistry, Genetics and Molecular Biology 21 14%
Neuroscience 11 7%
Engineering 5 3%
Other 10 7%
Unknown 33 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 November 2019.
All research outputs
#6,950,763
of 22,792,160 outputs
Outputs from Journal of Translational Medicine
#1,086
of 3,988 outputs
Outputs of similar age
#19,526
of 59,000 outputs
Outputs of similar age from Journal of Translational Medicine
#3
of 5 outputs
Altmetric has tracked 22,792,160 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 3,988 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 59,000 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.